228 related articles for article (PubMed ID: 17470562)
1. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes.
Zhao H; Przybylska M; Wu IH; Zhang J; Siegel C; Komarnitsky S; Yew NS; Cheng SH
Diabetes; 2007 May; 56(5):1210-8. PubMed ID: 17470562
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice.
Zhao H; Przybylska M; Wu IH; Zhang J; Maniatis P; Pacheco J; Piepenhagen P; Copeland D; Arbeeny C; Shayman JA; Aerts JM; Jiang C; Cheng SH; Yew NS
Hepatology; 2009 Jul; 50(1):85-93. PubMed ID: 19444873
[TBL] [Abstract][Full Text] [Related]
3. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
Alemzadeh R; Tushaus KM
Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
[TBL] [Abstract][Full Text] [Related]
4. TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats.
Ito R; Tsujihata Y; Matsuda-Nagasumi K; Mori I; Negoro N; Takeuchi K
Br J Pharmacol; 2013 Oct; 170(3):568-80. PubMed ID: 23848179
[TBL] [Abstract][Full Text] [Related]
5. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
6. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
7. Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase.
Yew NS; Zhao H; Hong EG; Wu IH; Przybylska M; Siegel C; Shayman JA; Arbeeny CM; Kim JK; Jiang C; Cheng SH
PLoS One; 2010 Jun; 5(6):e11239. PubMed ID: 20574539
[TBL] [Abstract][Full Text] [Related]
8. Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat.
Zigmond E; Zangen SW; Pappo O; Sklair-Levy M; Lalazar G; Zolotaryova L; Raz I; Ilan Y
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E72-8. PubMed ID: 18940939
[TBL] [Abstract][Full Text] [Related]
9. Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats.
Cordero-Herrera I; Martín MÁ; Escrivá F; Álvarez C; Goya L; Ramos S
J Nutr Biochem; 2015 Jul; 26(7):704-12. PubMed ID: 25814291
[TBL] [Abstract][Full Text] [Related]
10. Consumption of a high β-glucan barley flour improves glucose control and fatty liver and increases muscle acylcarnitines in the Zucker diabetic fatty rat.
Brockman DA; Chen X; Gallaher DD
Eur J Nutr; 2013 Oct; 52(7):1743-53. PubMed ID: 23229409
[TBL] [Abstract][Full Text] [Related]
11. Use of glycated hemoglobin to assess Glycemic control in Wistar diabetic fatty rats and Zucker fatty rats.
Albright AL; Johnson PR; Greene S; Stern JS
Obes Res; 1994 Nov; 2(6):535-9. PubMed ID: 16358402
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats.
Hofmann A; Brunssen C; Peitzsch M; Martin M; Mittag J; Jannasch A; Engelmann F; Brown NF; Weldon SM; Huber J; Streicher R; Deussen A; Eisenhofer G; Bornstein SR; Morawietz H
Endocrinology; 2016 Oct; 157(10):3844-3855. PubMed ID: 27526033
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with nateglinide and vildagliptin improves postprandial metabolic derangements in Zucker fatty rats.
Miura K; Kitahara Y; Yamagishi S
Horm Metab Res; 2010 Sep; 42(10):731-5. PubMed ID: 20625970
[TBL] [Abstract][Full Text] [Related]
14. Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats.
Chen L; McNulty J; Anderson D; Liu Y; Nystrom C; Bullard S; Collins J; Handlon AL; Klein R; Grimes A; Murray D; Brown R; Krull D; Benson B; Kleymenova E; Remlinger K; Young A; Yao X
J Pharmacol Exp Ther; 2010 Jul; 334(1):164-70. PubMed ID: 20413600
[TBL] [Abstract][Full Text] [Related]
15. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
[TBL] [Abstract][Full Text] [Related]
16. Effect of bariatric surgery combined with medical therapy versus intensive medical therapy or calorie restriction and weight loss on glycemic control in Zucker diabetic fatty rats.
Abegg K; Corteville C; Docherty NG; Boza C; Lutz TA; Muñoz R; le Roux CW
Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R321-9. PubMed ID: 25540099
[TBL] [Abstract][Full Text] [Related]
17. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
[TBL] [Abstract][Full Text] [Related]
18. DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats.
Zhang X; Yan G; Li Y; Zhu W; Wang H
Biomed Pharmacother; 2010 Nov; 64(9):647-51. PubMed ID: 20888730
[TBL] [Abstract][Full Text] [Related]
19. CPL207280, a Novel G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1-Specific Agonist, Shows a Favorable Safety Profile and Exerts Antidiabetic Effects in Type 2 Diabetic Animals.
Bazydlo-Guzenda K; Buda P; Matloka M; Mach M; Stelmach F; Dzida R; Smuga D; Hucz-Kalitowska J; Teska-Kaminska M; Vialichka V; Dubiel K; Kaminska B; Wieczorek M; Pieczykolan J
Mol Pharmacol; 2021 Oct; 100(4):335-347. PubMed ID: 34349026
[TBL] [Abstract][Full Text] [Related]
20. Caveolin gene transfer improves glucose metabolism in diabetic mice.
Otsu K; Toya Y; Oshikawa J; Kurotani R; Yazawa T; Sato M; Yokoyama U; Umemura S; Minamisawa S; Okumura S; Ishikawa Y
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C450-6. PubMed ID: 19923424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
